Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antithrombotic therapy after coronary stent placement

A Marzocchi1, G Piovaccari, C Marrozzini

  • 1Istituto di Malattie dell'Apparato Cardiovascolare, Università degli Studi, Bologna.

Cardiologia (Rome, Italy)
|September 17, 1998
PubMed
Summary

Acetylsalicylic acid (ASA) plus ticlopidine significantly reduced subacute stent thrombosis and bleeding complications compared to ASA plus warfarin after coronary stenting. This combination offers improved outcomes for patients undergoing stent procedures.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Poroelasticity derived from the microstructure for intrinsically incompressible constituents.

Zeitschrift fuer angewandte mathematik und physik·2025
Same author

[Nutritional and Functional assessment of peritoneal dialysis patients in the clinical practice: Report from MITO-DP Group].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2016
Same author

First results of an eye lens dosimetry survey in an interventional cardiology department.

Journal of radiological protection : official journal of the Society for Radiological Protection·2015
Same author

Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013
Same author

Stable and unstable angina pectoris.

Platelets·2010
Same author

Changes in exercise capacity induced by heart transplantation: prognostic and therapeutic implications.

Scandinavian journal of medicine & science in sports·2010

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Pharmacology

Background:

  • Subacute stent thrombosis and bleeding complications are significant limitations following coronary stenting.
  • Current antithrombotic therapy after coronary stent placement lacks standardization.
  • Intensive anticoagulant therapy, such as warfarin, poses risks of hemorrhagic complications.

Purpose of the Study:

  • To compare the efficacy and safety of two antithrombotic regimens following Palmaz-Schatz coronary stent implantation.
  • To evaluate the incidence of subacute stent thrombosis and major bleeding complications between treatment groups.

Main Methods:

  • A total of 338 Palmaz-Schatz stents were implanted in 285 patients between January 1994 and December 1995.
  • Group A (135 patients) received acetylsalicylic acid (ASA) and warfarin, with intravenous heparin bridging.

Related Experiment Videos

  • Group B (146 patients) received ASA plus ticlopidine, with subcutaneous heparin post-procedure.

    • Main Results:

    • Subacute stent thrombosis occurred in 3.9% of patients (9 in Group A vs. 2 in Group B; p = 0.04).
    • Major bleeding complications were observed in 6 patients in Group A versus 2 in Group B.
    • The ASA plus ticlopidine group demonstrated a statistically significant reduction in both cardiac events and bleeding.

    Conclusions:

    • Antithrombotic therapy with acetylsalicylic acid (ASA) plus ticlopidine is superior to ASA plus warfarin in reducing subacute stent thrombosis after coronary stenting.
    • The ASA plus ticlopidine regimen also significantly decreases major hemorrhagic complications.
    • This combination therapy offers improved clinical benefits and safety profiles for patients receiving coronary stents.